Martínez-Mota Lucía, Estrada-Camarena Erika, López-Rubalcava Carolina
Subdirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calzada México-Xochimilco 101, San Lorenzo Huipulco, Tlalpan, México 14370, D.F.
Psychopharmacology (Berl). 2002 Dec;165(1):60-6. doi: 10.1007/s00213-002-1222-z. Epub 2002 Oct 23.
Indorenate has been proposed to possess antihypertensive, anorectic, stimulus control and anxiolytic-like actions. This compound has affinity mainly for the serotonergic(1A/1B) receptors, hence it could possess antidepressant-like activity.
The general purpose of this study was to explore the possible antidepressant-like effects of the serotonergic compound indorenate in the forced swimming test (FST).
In a first approach, a comparison of the actions of several doses of indorenate (2.5, 5.0, 10 mg/kg) with those of other 5-HT(1A) agonists, buspirone (5.0, 10.0 mg/kg) and 8-OH-DPAT (0.25, 0.50, 1.0 mg/kg), was performed in the FST. Secondly, in order to determine the serotonergic receptors that are participating in indorenate's action, different doses of serotonergic antagonists were administered. The compounds used were the 5-HT(1A/1B) and beta-adrenergic antagonist pindolol (2.5, 5.0 mg/kg), the 5-HT(1B)receptor antagonist GR 55562 (0.75, 1.5, 3.0 mg/kg), the 5-HT(1A) antagonist WAY 100635 (0.25, 0.5, 1.0 mg/kg) and the 5-HT(2) antagonist ketanserin (1.0, 2.0, 4.0 mg/kg).
Indorenate (10 mg/kg), 8-OH-DPAT (1.0 mg/kg) and buspirone (5.0 and 10.0 mg/kg) reduced immobility behaviour in the FST, considered as an antidepressant-like effect. Both doses of pindolol (2.5 and 5.0 mg/kg) and WAY 100635 (0.5 and 1.0 mg/kg) antagonised the antidepressant-like effect of indorenate. Neither 5-HT(1B) (GR55562) nor 5-HT(2)(ketanserin) antagonists produced changes in the effect of indorenate in the FST.
Indorenate produces antidepressant-like actions in the FST that are mediated by the stimulation of 5-HT(1A) receptors.
吲哚尼酸被认为具有抗高血压、抑制食欲、刺激控制和抗焦虑样作用。该化合物主要对血清素能(1A/1B)受体具有亲和力,因此可能具有抗抑郁样活性。
本研究的总体目的是在强迫游泳试验(FST)中探索血清素能化合物吲哚尼酸可能的抗抑郁样作用。
首先,在FST中比较了几种剂量的吲哚尼酸(2.5、5.0、10mg/kg)与其他5-HT(1A)激动剂丁螺环酮(5.0、10.0mg/kg)和8-OH-DPAT(0.25、0.50、1.0mg/kg)的作用。其次,为了确定参与吲哚尼酸作用的血清素能受体,给予了不同剂量的血清素能拮抗剂。所用化合物为5-HT(1A/1B)和β-肾上腺素能拮抗剂吲哚洛尔(2.5、5.0mg/kg)、5-HT(1B)受体拮抗剂GR 55562(0.75、1.5、3.0mg/kg)、5-HT(1A)拮抗剂WAY 100635(0.25、0.5、1.0mg/kg)和5-HT(2)拮抗剂酮色林(1.0、2.0mg/kg)。
吲哚尼酸(10mg/kg)、8-OH-DPAT(1.0mg/kg)和丁螺环酮(5.0和10.0mg/kg)减少了FST中的不动行为,这被视为抗抑郁样作用。两种剂量的吲哚洛尔(2.5和5.0mg/kg)和WAY 100635(0.5和1.0mg/kg)均拮抗了吲哚尼酸的抗抑郁样作用。5-HT(1B)(GR55562)和5-HT(2)(酮色林)拮抗剂均未改变吲哚尼酸在FST中的作用。
吲哚尼酸在FST中产生抗抑郁样作用,该作用由5-HT(1A)受体的刺激介导。